These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21296365)

  • 21. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.
    Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A
    Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females.
    de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; Romero E
    Int J Obes (Lond); 2010 Mar; 34(3):511-5. PubMed ID: 20065978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of visfatin in the prediction of metabolic syndrome: a multi-factorial analysis.
    Esteghamati A; Morteza A; Zandieh A; Jafari S; Rezaee M; Nakhjavani M; Jamali A; Esteghamati AR; Khalilzadeh O
    J Cardiovasc Transl Res; 2012 Aug; 5(4):541-6. PubMed ID: 22585407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.
    Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M;
    PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; Sagrado MG; Conde R; Velasco MC; Alvarez T; Pacheco D; González JM
    Dig Dis Sci; 2009 Aug; 54(8):1772-7. PubMed ID: 19005759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients.
    El-Hini SH; Mohamed FI; Hassan AA; Ali F; Mahmoud A; Ibraheem HM
    Rheumatol Int; 2013 Sep; 33(9):2283-9. PubMed ID: 23471745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients.
    Gunes F; Akbal E; Cakir E; Akyurek O; Altunbas M; Ozbek M
    Intern Med; 2012; 51(6):553-7. PubMed ID: 22449661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of sodium restricted diet on plasma visfatin levels in hypertensive patients with visceral obesity.
    Rotkegel S; Chudek J; Spiechowicz-Zaton U; Ficek R; Adamczak M; Wiecek A
    Kidney Blood Press Res; 2013; 37(2-3):124-31. PubMed ID: 23615125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neck circumference and clustered cardiovascular risk factors in children and adolescents: cross-sectional study.
    Castro-Piñero J; Delgado-Alfonso A; Gracia-Marco L; Gómez-Martínez S; Esteban-Cornejo I; Veiga OL; Marcos A; Segura-Jiménez V;
    BMJ Open; 2017 Sep; 7(9):e016048. PubMed ID: 28899889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary intake and cardiometabolic biomarkers in relation to insulin resistance and hypertension in a middle-aged and elderly population in Beijing, China.
    Wang J; Hong Z; Wu L; Ding B; Bi Y; Gu Z; Li W
    Appl Physiol Nutr Metab; 2017 Aug; 42(8):869-875. PubMed ID: 28453944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.